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a b s t r a c t
This study evaluates the validity of the Step Activity Monitor (SAM) for assessing physical
activity in neuropathic people with diabetes and the relation with self-reported physical
activity. SAM was shown to be valid. Although SAM and self-reported physical activity are
correlated, caution should be taken with self-reported data when monitoring individuals.
# 2010 Elsevier Ireland Ltd. Open access under the Elsevier OA license.
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Physical activity, such as walking is an important component
in the management of diabetes [1]. Because of these health
related benefits, monitoring of physical activity is frequently
performed. The purpose of the present study was to evaluate
the validity of the Step Activity Monitor (SAM) StepWatch 3 in
neuropathic people with diabetes and to investigate the
relationship between SAM, self-reported physical activity
and walking capacity.
2. Research design and methods
Twenty-four (17 male and 7 female) people (60  9 years,
average diabetes duration 18.1  16.7 years) from a Diabetes
Foot Clinic in a Dutch academic hospital participated. The* Corresponding author at: Department of Rehabilitation, Academic M
Amsterdam, The Netherlands. Tel.: +31 20 5663669; fax: +31 20 56691
E-mail address: carine.van.schie@gmail.com (Carine H.M. van Sch
Abbreviations: MET, metabolic equivalent of task.
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doi:10.1016/j.diabres.2010.12.013inclusion criteria were: type 1 or 2 diabetes, inability to feel the
10-g (5.07) Semmes Weinstein monofilament on the hallux of
both feet, ability to walk at least 4 min and age between 18 and
75. Patients with Charcot neuroarthropathy, an active foot
ulcer or an (partial) amputation were excluded. This study was
approved by the local Medical Ethics Committee and informed
consent was obtained from all participants.
The SAM (Cymateach, Seattle, USA), an accelerometer-
based monitor, was used to assess physical activity. Validity of
the SAM was assessed during a 4 min walking test at
comfortable speed. The number of strides (one stride equals
two steps) was determined using a hand-held counter.
Average daily physical activity was determined over 2 days
(excluding days travelling to and from the clinic) and was
defined as the mean number of strides/day and min/day.
Participants were instructed to wear the SAM during all
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Activity Questionnaire (IPAQ) was used to determine self-
reported physical activity during the last 7 days (www.EM-
GO.nl/researchtools/ipaq.asp). Walking capacity was deter-
mined as the distance walked in 2-min at self-preferred
speed. A mean of two tests (>5 days between the tests)
was used.
Validity of the SAM was assessed as the percentage
agreement, calculated as (1  (difference/observer count)) 
100%. The SAM was considered a valid device if percentage
agreement was >95%. For the MET-min/week calculation the
IPAQ protocol version November 2005 was used (www.ipaq.-
ki.se). Associations were investigated using Pearson and
Spearman correlation coefficients, using a significance level
of p < 0.05.
3. Results
The SAMrecordedwith an accuracy of 98.6% (range 94.3–100%)
compared with observer-counted strides.
The mean of SAM recording was 5062 strides/day (range
695–11,564) and 355 min/day of physical activity (range 72–
726). Median (p25/p75) self-reported physical activity was
2517 (686/10,016) MET-min/week and 713 (150/2460) min/
week. Significant correlations were observed between SAM
(strides/day) and IPAQ MET-min/week (Spearman’s r = 0.49,
p < 0.05) and between SAM recorded min activity/day and
IPAQ calculated min activity/week (Spearman’s r = 0.43,
p < 0.05) (Fig. 1). The graph shows that IPAQ activity may
have a large difference from actual activity, indicating an
underestimation of IPAQ in subjects with low physical
activity.
Mean walking capacity (distance walked in 2 min) was
129.3 m (range 58–213.5). No significant relation was observed
between walking capacity and SAM recorded activity
expressed as strides/day (p = 0.095) or min/day (p = 0.178).
[()TD$FIG]
Fig. 1 – Relation between IPAQ self-reported number of min
activity/week and SAM recorded minutes activity/week
(Spearman’s r = 0.43, p < 0.05). The line indicates the ‘line
of identity’.4. Discussion
This study shows a high accuracy (98.6%) of SAM in people
with diabetes with peripheral neuropathy and confirms
previous studies demonstrating the validity of SAM in other
populations (96–99.9%) [2–6].
The recorded physical activity was also significantly
associated with self-reported activity, with a higher correla-
tion (r = 0.49) than previous studies comparing IPAQ and aMTI
accelerometer (r = 0.33 and r = 0.36) [7,8]. The difference may
be related to type of subjects studied, number of days recorded
or the measurement device.
A limitation of our study is that SAM recordings were only
madeduring2daysand that IPAQwascompleted thedaybefore
SAM-recording started. Another limitation is subject’s aware-
ness of themeasurement, whichmay result in a bias of greater
activity than usual. Additionally, the lack of a control group
limits the comparison of activity data with healthy subjects.
Although SAM and IPAQ determined physical activity were
significantly associated, self-reported IPAQ underestimated
activity in people with low activity. This may be because IPAQ
only measures activities lasting at least 10 min, while SAM
records every activity. Because of the limitations of self-
reported physical activity [9], it is recommended to use the
IPAQ for monitoring populations, whereas activity monitors
such as the SAM are more suitable for individual monitoring.
We did not find a relation between walking capacity and
physical activity. This indicates that at group level, capacity is
not the limiting factor of physical activity, thus good walkers
do not necessarily walk more than poor walkers. Therefore, it
should be possible to stimulate people to increase physical
activity.
The mean physical activity level reported in the present
study compares well to the guideline of 10,000 steps/day
(equal to 5000 strides/day) [10]. Compared with other studies
using SAM in people with diabetes and neuropathy, the
activity level was slightly higher than in UK subjects without a
history of foot ulceration (4409  1953 strides/day) and much
higher than two US studies (3908 and 3293 steps/day respec-
tively in people without history of plantar ulceration and
subjects with andwithout amputation) [11–13]. The difference
can only partly be explained by the slightly older subjects and
more severe neuropathic complications in one of the US
studies and is possibly also related to cultural differences. In
our subjects we observed a wide range of 695–11,564 strides/
day. Of all participants 33% had a low activity lifestyle
(<3750 strides/day) and therefore these subjects may benefit
most from an intervention to increase physical activity [10].
5. Conclusions
In conclusion, the SAM was shown to be a valid tool to assess
physical activity in people with diabetes with peripheral
neuropathy. Although actual SAM recorded and self-reported
IPAQ activities were associated, it is preferable not to rely on
self-reported activity when monitoring individual subjects,
but to directly assess activity with a monitor. Activity
monitoring should be used to objectively assess activity and
the effectiveness of measures to promote physical activity.
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